Atria Investments Inc Decreases Holdings in STERIS plc (NYSE:STE)

Atria Investments Inc trimmed its holdings in shares of STERIS plc (NYSE:STE) by 10.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,516 shares of the medical equipment provider’s stock after selling 1,293 shares during the period. Atria Investments Inc’s holdings in STERIS were worth $2,162,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Assetmark Inc. boosted its position in STERIS by 30.3% during the 4th quarter. Assetmark Inc. now owns 17,470 shares of the medical equipment provider’s stock worth $3,591,000 after purchasing an additional 4,060 shares during the period. J.Safra Asset Management Corp boosted its position in STERIS by 208.7% in the 4th quarter. J.Safra Asset Management Corp now owns 460 shares of the medical equipment provider’s stock valued at $94,000 after buying an additional 311 shares during the last quarter. Victory Capital Management Inc. boosted its position in STERIS by 0.8% in the 4th quarter. Victory Capital Management Inc. now owns 70,401 shares of the medical equipment provider’s stock valued at $14,472,000 after buying an additional 586 shares during the last quarter. Alta Capital Management LLC boosted its position in STERIS by 5.8% in the 4th quarter. Alta Capital Management LLC now owns 1,225 shares of the medical equipment provider’s stock valued at $252,000 after buying an additional 67 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in STERIS by 3.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 569,837 shares of the medical equipment provider’s stock valued at $117,136,000 after buying an additional 18,384 shares during the last quarter. 94.69% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have weighed in on STE shares. JMP Securities reissued a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Stephens reissued an “overweight” rating and issued a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Finally, Piper Sandler upped their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, STERIS presently has a consensus rating of “Moderate Buy” and an average target price of $258.75.

STERIS Stock Performance

Shares of STERIS stock opened at $233.02 on Monday. The firm has a market cap of $22.89 billion, a PE ratio of 49.47 and a beta of 0.92. The firm’s 50-day simple moving average is $216.96 and its 200-day simple moving average is $222.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Equities analysts forecast that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be paid a dividend of $0.57 per share. The ex-dividend date is Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 0.98%. STERIS’s dividend payout ratio (DPR) is 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.